Beef and Plant Burger Metabolomics Study
Effects of Different Sources of Beef and Plant-based Meat Alternatives on Postprandial Inflammatory and Metabolic Profiles of Consumers
1 other identifier
interventional
36
1 country
1
Brief Summary
The purpose of this study is to determine the effects of meat on inflammatory and metabolite profiles in middle-aged individuals after an acute meal. Up to 36 adults, who are overweight or obese and between 30-60 years old will undergo a consent/screening visit, followed by three study visits. On separate visits to the clinical research facilities at the Center for Human Nutrition Studies, participants will consume either 9 oz (250 grams) of cooked grain-fed beef, grass-fed beef, or a plant-based meat alternative (Impossible Burger). Blood will be drawn prior to food consumption and three more times after eating the meal at 1h, 3h, and 5h after participants finishing their meal. The investigators will use those blood samples to determine the impacts of these foods on inflammatory markers and metabolite profiles (compounds that circulate in our blood such as amino acids, fatty acids, and phenolics).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Feb 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 19, 2022
CompletedFirst Posted
Study publicly available on registry
January 19, 2023
CompletedStudy Start
First participant enrolled
February 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 23, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 16, 2024
CompletedApril 30, 2024
April 1, 2024
11 months
December 19, 2022
April 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Inflammatory cytokine biomarker (IL-6) concentrations in plasma samples
Inflammatory biomarker concentrations of IL-6 (pg/ml) will be measured using ELISA kits at the Center for Human Nutrition Studies at Utah State University. Blood samples will be obtained via phlebotomy before the consumption of the meal, and at time points 60 minutes, 180 minutes, and 300 minutes after consumption of the meal, centrifuged immediately and stored at -80ºC until analyses are performed.
Change from fasting concentrations after eating.
Inflammatory cytokine biomarker (C-reactive protein) concentrations in plasma samples
Inflammatory biomarker concentrations of C-reactive protein (CRP; ng/ml) will be measured using ELISA kits at the Center for Human Nutrition Studies at Utah State University. Blood samples will be obtained before the consumption of the meal, and at time points 60 minutes, 180 minutes, and 300 minutes after consumption of the meal, centrifuged immediately, and stored at -80ºC until analyses are performed.
Change from fasting concentrations after eating.
Inflammatory cytokine biomarker (TNF-alpha) concentrations in plasma samples
Inflammatory biomarker concentrations of TNF-alpha (pg/ml) will be measured using ELISA kits at the Center for Human Nutrition Studies at Utah State University. Blood samples will be obtained before the consumption of the meal, and at time points 60 minutes, 180 minutes, and 300 minutes after consumption of the meal, centrifuged immediately, and stored at -80ºC until analyses are performed.
Change from fasting concentrations after eating.
Inflammatory cytokine biomarker (Vascular Adhesion Molecule-1) concentrations in plasma samples
Inflammatory biomarker concentrations of Vascular Adhesion Molecule-1 (ng/ml) will be measured using ELISA kits at the Center for Human Nutrition Studies at Utah State University. Blood samples will be obtained before the consumption of the meal, and at time points 60 minutes, 180 minutes, and 300 minutes after consumption of the meal, centrifuged immediately, and stored at -80ºC until analyses are performed.
Change from fasting concentrations after eating.
Relative abundance of metabolites in plasma samples using triple quad LC/MS-MS
Relative abundance (arbitrary units) of plasma metabolites after each meal will be measured using high-performance liquid chromatography tandem mass-spectrometry (LC/MS-MS). This analysis allows the simultaneous high-resolution measurement of a broad range of metabolites and will give insight into how food-derived metabolites from different meals impact metabolic pathways of human health. Blood samples will be obtained before each meal, and three times after the meal is consumed at time 60 minutes, 180 minutes, and 300 minutes, and centrifuged immediately and stored at -80ºC until analyses are performed. Multivariate statistical analysis and Partial least squares Discriminant Analysis will be used to identify features changed over time for each meal.
Change from fasting concentrations after eating.
Secondary Outcomes (3)
Satiety Questionnaire
Immediately before meal
Taste Questionnaire
Immediately after eating
Mood Questionnaires
Change in mood scores from baseline after eating.
Study Arms (6)
Sequence 1: Grain-Fed, Grass-Fed, Impossible
ACTIVE COMPARATOROn the first visit, a grain-fed beef burger (250 grams) will be consumed. On the second visit, a grass-fed beef burger (250 grams) will be consumed. On the third visit, an Impossible BurgerTM (250 grams) will be consumed.
Sequence 2: Grass-Fed, Grain-Fed, Impossible
ACTIVE COMPARATOROn the first visit, a grass-fed beef burger (250 grams) will be consumed. On the second visit, a grain-fed beef burger (250 grams) will be consumed. On the third visit, an Impossible BurgerTM (250 grams) will be consumed.
Sequence 3: Impossible, Grass-Fed, Grain-Fed
ACTIVE COMPARATOROn the first visit, an Impossible BurgerTM (250 grams) will be consumed. On the second visit, a grass-fed beef burger (250 grams) will be consumed. On the third visit, a grain-fed beef burger (250 grams) will be consumed.
Sequence 4: Impossible, Grain-Fed, Grass-Fed
ACTIVE COMPARATOROn the first visit, an Impossible BurgerTM (250 grams) will be consumed. On the second visit, a grain-fed beef burger (250 grams) will be consumed. On the third visit, a grass-fed beef burger (250 grams) will be consumed.
Sequence 5: Grain-Fed, Impossible, Grass-Fed
ACTIVE COMPARATOROn the first visit, a grain-fed beef burger (250 grams) will be consumed. On the second visit, an Impossible BurgerTM (250 grams) will be consumed. On the third visit, a grass-fed beef burger (250 grams) will be consumed.
Sequence 6: Grass-Fed, Impossible, Grain-Fed
ACTIVE COMPARATOROn the first visit, a grass-fed beef burger (250 grams) will be consumed. On the second visit, an Impossible BurgerTM (250 grams) will be consumed. On the third visit, a grain-fed beef burger (250 grams) will be consumed.
Interventions
Bowl of grain-fed beef hamburger cooked without seasonings. 250 grams of uncooked hamburger weighed out, then cooked in a non-stick pan for 8 minutes, no seasoning or oils were used and rendered fat was poured into serving bowl.
Bowl of grass-fed, grass-finished beef hamburger cooked without seasonings. 250 grams of uncooked hamburger weighed out, then cooked in a non-stick pan for 8 minutes, no seasoning or oils were used and rendered fat was poured into serving bowl.
Bowl of plant-based Impossible burger cooked without seasonings. 250 grams of uncooked Impossible burger weighed out, then cooked in a non-stick pan for 8 minutes, no seasoning or oils were used and rendered fat was poured into serving bowl.
Eligibility Criteria
You may qualify if:
- Age ≥30 and ≤60 years;
- BMI ≥25 and ≤35 kg/m2;
- Weight stable in last 3 months (Loss or gain \<4%);
- Hemoglobin A1C (HbA1C) ≤6.4%;
- Fasting plasma glucose concentration \<126 mg/dl;
- Subjects must be able to speak and understand English to participate in this study
You may not qualify if:
- Use of medications that are known to affect the study outcome measures (e.g., NSAIDs, corticosteroids) or increase the risk of study procedures (e.g., anticoagulants) that cannot be temporarily discontinued for this study;
- Consuming \>14 drinks per week;
- Use of cigarettes (or other tobacco products) in last 3 months;
- COVID vaccine within the last two weeks;
- Engaged in high-level competitive exercise (e.g., triathlon, marathon, powerlifting);
- Any inflammatory diseases(e.g. autoimmune diseases, coeliac disease, glomerulonephritis, hepatitis, inflammatory bowel disease, arthritis);
- Diagnoses of active malignancy, congestive heart failure, diabetes mellitus and/or chronic obstructive pulmonary disease;
- Use of antibiotics in last 60 days;
- Pregnant (or planning to in the next month) or lactating women;
- Soy allergy;
- Subjects who the study PI considers unable to safely complete the study protocol;
- Persons who are not able to grant voluntary informed consent;
- Persons who are unable or unwilling to follow the study protocol or who, for any reason, the research team considers not an appropriate candidate for this study, including non-compliance with screening appointments or study visits;
- Vegetarian
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Utah State Universitylead
- Duke Universitycollaborator
- United States Department of Agriculture (USDA)collaborator
Study Sites (1)
Center for Human Nutrition Studies
Logan, Utah, 84322, United States
Related Publications (1)
Cloward J, Mason O, DeJesus I, Broadbent J, Payne T, Wengreen HJ, van Vliet S. Comparing Postprandial Inflammatory Responses to a Plant-Based Meat Alternative, Grass-Finished Beef, and Grain-Finished Beef in Healthy Middle-Aged Adults: A Three-Group Randomized Crossover Trial. Am J Clin Nutr. 2026 Jan 8:101192. doi: 10.1016/j.ajcnut.2026.101192. Online ahead of print.
PMID: 41519303DERIVED
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Stephan van Vliet, PhD
Utah State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Participants will not know which type of burger they consume.
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
December 19, 2022
First Posted
January 19, 2023
Study Start
February 1, 2023
Primary Completion
December 23, 2023
Study Completion
December 16, 2024
Last Updated
April 30, 2024
Record last verified: 2024-04
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, ANALYTIC CODE
- Time Frame
- Study protocol is available immediately. The analytical data will be available upon publication.
- Access Criteria
- Freely available.
The study protocol is attached to the ClinicalTrials.gov. Any collected data through RedCap and wet-lab assays will be made available upon publication. The metabolomics data will be deposited on Metabolomics Workbench (or a comparable repository) upon submission for publication.